Alimera sciences announces second quarter 2022 financial results

Atlanta, july 27, 2022 (globe newswire) -- alimera sciences, inc. (nasdaq: alim) (alimera), a global pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals for the treatment of retinal diseases, today announced financial results for the second quarter of 2022. alimera will host a conference call today at 9:00 a.m. edt to discuss these results.
ALIM Ratings Summary
ALIM Quant Ranking